[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

IL115843A0 - Pharmaceutical composition containing cisapride-(l)-tartrate - Google Patents

Pharmaceutical composition containing cisapride-(l)-tartrate

Info

Publication number
IL115843A0
IL115843A0 IL11584395A IL11584395A IL115843A0 IL 115843 A0 IL115843 A0 IL 115843A0 IL 11584395 A IL11584395 A IL 11584395A IL 11584395 A IL11584395 A IL 11584395A IL 115843 A0 IL115843 A0 IL 115843A0
Authority
IL
Israel
Prior art keywords
tartrate
pharmaceutical composition
composition containing
containing cisapride
cisapride
Prior art date
Application number
IL11584395A
Other languages
English (en)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IL115843A0 publication Critical patent/IL115843A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4468Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cereal-Derived Products (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
IL11584395A 1994-11-02 1995-11-01 Pharmaceutical composition containing cisapride-(l)-tartrate IL115843A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94203184 1994-11-02

Publications (1)

Publication Number Publication Date
IL115843A0 true IL115843A0 (en) 1996-01-31

Family

ID=8217338

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11584395A IL115843A0 (en) 1994-11-02 1995-11-01 Pharmaceutical composition containing cisapride-(l)-tartrate

Country Status (29)

Country Link
US (2) US6153623A (xx)
EP (1) EP0789572A1 (xx)
JP (1) JP3182423B2 (xx)
KR (1) KR100255521B1 (xx)
AP (1) AP658A (xx)
AR (1) AR001765A1 (xx)
AU (1) AU704284B2 (xx)
BG (1) BG63244B1 (xx)
BR (1) BR9509565A (xx)
CA (1) CA2203663C (xx)
CZ (1) CZ287844B6 (xx)
EE (1) EE03510B1 (xx)
FI (1) FI971856A0 (xx)
HR (1) HRP950539A2 (xx)
HU (1) HUT77887A (xx)
IL (1) IL115843A0 (xx)
MY (1) MY113092A (xx)
NO (1) NO312538B1 (xx)
NZ (1) NZ295166A (xx)
OA (1) OA10419A (xx)
PL (1) PL181470B1 (xx)
RO (1) RO116042B1 (xx)
RU (1) RU2143890C1 (xx)
SK (1) SK54297A3 (xx)
TR (1) TR199501351A2 (xx)
TW (1) TW466114B (xx)
UA (1) UA50721C2 (xx)
WO (1) WO1996014070A1 (xx)
ZA (1) ZA959221B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA959221B (en) * 1994-11-02 1997-04-30 Janssen Pharmaceutica Nv Cisapride extended release
WO1997020562A1 (en) * 1995-12-01 1997-06-12 Janssen Pharmaceutica N.V. Cisapride sustained release
ATE220543T1 (de) * 1996-04-23 2002-08-15 Janssen Pharmaceutica Nv Rasch-freisetzende ph-unabhängige feste dosisformen enthaltend cisaprid
CA2275604A1 (en) * 1997-01-03 1998-07-09 Kenneth Iain Cumming Sustained release cisapride mini-tablet formulation
WO1998056364A1 (en) * 1997-06-11 1998-12-17 Janssen Pharmaceutica N.V. IMMEDIATE RELEASE pH-INDEPENDENT SOLID DOSAGE FORM OF (+)- OR (-)-CISAPRIDE
TW407058B (en) * 1998-07-17 2000-10-01 Dev Center Biotechnology Oral cisapride dosage forms with an extended duration
PL198797B1 (pl) * 1999-03-31 2008-07-31 Janssen Pharmaceutica Nv Zastosowanie wstępnie żelowanej skrobi
EP1060743A1 (en) * 1999-06-17 2000-12-20 Development Center For Biotechnology Oral cisapride dosage forms with an extended duration
PT1345595E (pt) * 2000-09-29 2007-08-13 Solvay Pharm Bv Formulação farmacêutica de libertação prolongada independente da força iónica
DE60228939D1 (de) * 2002-05-21 2008-10-30 Watson Lab Inc Pharmazeutische Zusammensetzung mit verzögerter Freisetzung
WO2007123021A1 (ja) 2006-04-12 2007-11-01 Nippon Soda Co., Ltd. 徐放性錠剤の製造方法
RU2356532C2 (ru) * 2007-06-01 2009-05-27 Открытое Акционерное Общество "Отечественные Лекарства" Фармацевтическая композиция проксодолола с контролируемым высвобождением
US20120065221A1 (en) 2009-02-26 2012-03-15 Theraquest Biosciences, Inc. Extended Release Oral Pharmaceutical Compositions of 3-Hydroxy-N-Methylmorphinan and Method of Use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1183847A (en) * 1981-10-01 1985-03-12 Georges Van Daele N-(3-hydroxy-4-piperidinyl)benzamide derivatives
US5057525A (en) * 1981-10-01 1991-10-15 Janssen Pharmaceutica N.V. Novel N-(3-hydroxy-4-piperidinyl) benzamide derivatives
WO1993018755A1 (en) * 1992-03-25 1993-09-30 Depomed Systems, Incorporated Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
WO1994001112A1 (en) * 1992-07-07 1994-01-20 Sepracor Inc. Methods of using (-) cisapride for the treatment of gastro-esophageal reflux disease and other disorders
ZA959221B (en) * 1994-11-02 1997-04-30 Janssen Pharmaceutica Nv Cisapride extended release

Also Published As

Publication number Publication date
BG101401A (en) 1997-12-30
AU704284B2 (en) 1999-04-15
NO971832D0 (no) 1997-04-21
AR001765A1 (es) 1997-12-10
SK54297A3 (en) 1997-10-08
EP0789572A1 (en) 1997-08-20
EE03510B1 (et) 2001-10-15
CZ287844B6 (en) 2001-02-14
PL319948A1 (en) 1997-09-01
AU3844795A (en) 1996-05-31
MX9703249A (es) 1997-07-31
WO1996014070A1 (en) 1996-05-17
KR100255521B1 (ko) 2000-05-01
US6274599B1 (en) 2001-08-14
NO312538B1 (no) 2002-05-27
CA2203663A1 (en) 1996-05-17
AP658A (en) 1998-08-17
TW466114B (en) 2001-12-01
US6153623A (en) 2000-11-28
BG63244B1 (bg) 2001-07-31
BR9509565A (pt) 1997-09-16
HUT77887A (hu) 1998-09-28
TR199501351A2 (tr) 1996-06-21
JP3182423B2 (ja) 2001-07-03
PL181470B1 (pl) 2001-07-31
ZA959221B (en) 1997-04-30
NO971832L (no) 1997-04-21
FI971856A (fi) 1997-04-30
CA2203663C (en) 2002-04-30
FI971856A0 (fi) 1997-04-30
UA50721C2 (uk) 2002-11-15
NZ295166A (en) 1999-03-29
AP9700969A0 (en) 1997-04-30
MY113092A (en) 2001-11-30
JPH09511760A (ja) 1997-11-25
HRP950539A2 (en) 1997-08-31
RU2143890C1 (ru) 2000-01-10
RO116042B1 (ro) 2000-10-30
CZ124497A3 (en) 1997-08-13
EE9700105A (et) 1997-12-15
OA10419A (en) 2001-12-06

Similar Documents

Publication Publication Date Title
HUP9802999A3 (en) Pharmaceutical composition containing n-propargyl-1-aminoindan
HUP9602056A2 (en) Novel pharmaceutical composition containing phenofibrate
ZA957247B (en) Pharmaceutical compositions
EP0803255A4 (en) DRUG
IL113329A0 (en) Benzamide-containing pharmaceutical compositions
GB9418609D0 (en) Pharmaceutical compositions
IL115843A0 (en) Pharmaceutical composition containing cisapride-(l)-tartrate
CY2298B1 (en) Pharmaceutical composition containing 4-oxo-butynic acids
ZA954469B (en) Pharmaceutical compositions
HU9503031D0 (en) Pharmaceutical composition containing von willerbrand factor
GB9406835D0 (en) Pharmaceutical compositions
GB2295825B (en) Pharmaceutical compositions
HU9601821D0 (en) Pharmaceutical compositions
HU9400096D0 (en) Pharmaceutical compositions
GB2285923B (en) Pharmaceutical compositions containing N-acetal-cysteine
IL115853A (en) Aryloxycycloalkenyl and aryloxyiminocyclo-alkenylhydroxyureas and pharmaceutical compositions containing these compounds
GB9707483D0 (en) Pharmaceutical compositions
HU9400523D0 (en) Pharmaceutical composition
GB9424470D0 (en) Pharmaceutical composition
GB9405024D0 (en) Pharmaceutical composition
GB9405025D0 (en) Pharmaceutical composition
GB9414182D0 (en) Pharmaceutical composition
GB9414183D0 (en) Pharmaceutical composition
GB9420991D0 (en) Pharmaceutical composition
GB9421239D0 (en) Pharmaceutical composition